Quote:Republicans need to decide if a conservative health care system is worth the cost.
Updated by Ezra Klein@ezraklein Mar 27, 2017, 1:50pm EDT
Paul Krugman has a column Monday offering Republicans some advice for how to improve Obamacare.
This paragraph is worth calling out:
One important answer would be to spend a bit more money.
Obamacare has turned out to be remarkably cheap; the Congressional Budget Office now projects its cost to be about a third lower than it originally expected, around 0.7 percent of G.D.P. In fact, it’s probably too cheap.
A report from the nonpartisan Urban Institute argues that the A.C.A. is “essentially underfunded,” and would work much better — in particular, it could offer policies with much lower deductibles — if it provided somewhat more generous subsidies.
The report’s recommendations would cost around 0.2 percent of G.D.P.; or to put it another way, would be around half as expensive as the tax cuts for the wealthy Republicans just tried and failed to ram through as part of Trumpcare.
Let’s state the obvious: Republicans will not hear “spend a bit more money” as friendly advice when it comes to Obamacare. But to an extent I don’t think they appreciate, “spend a bit more money” is necessary for their health care goals, too.
Republicans in particular, but Americans in general, are confounded by an unusual dynamic in health policy: The health care systems that spend the least rely on government the most.
This is difficult for Americans to grok because anti-government rhetoric takes as a given that government services cost more — we’ve all heard the stories of Pentagon procurement gone awry, or some agency somewhere spending absurd sums on pencil trays.
But in health care, the cheapest, highest-performing systems all do the same thing — they let government set prices centrally. That’s true in the UK’s absurdly inexpensive, and fully socialized, health care system; but it’s also true in the Singaporean system, which conservatives often hold up as a model.
Hell, it’s even true in the American system! Medicare and Medicaid pay much less for health services than private insurers. That’s one reason Obamacare relied so heavily on the Medicaid expansion — Democrats couldn’t afford to subsidize private insurance for everyone who needed it, and so they turned to the cheaper insurance Medicaid offered.
Even now, the part of Obamacare that needs more money is the part based on conservative ideas — the regulated marketplaces where people buy private insurance.
The downside: price regulation can cut innovation, freedom.
If you ask conservative health care experts about America’s sky-high health care spending, they tend to treat it as a necessary cost of the health system we want. Yes, other countries spend much less than we do on health care, but that’s because they’re freeloading on the innovation our high spending produces.
As long as America is paying through the nose for new pharmaceuticals, there’s good reason for pharmaceutical companies to pump billions and billions of dollars into developing new drugs. If America moved to UK-style regulated pricing, then sure, we’d spend less money, but pharmaceutical companies would stop investing so much in discovering new drugs, and we’d lose so much innovation that the cure would be worse than the disease.
I don’t fully buy this argument — if innovation is our goal, we can incentivize it in more targeted ways than paying any price for anything drug companies develop — but there’s definitely power to it.
However, if conservatives are going to be the last best hope for unregulated prices in the health care sector, they need to accept that the health care system they’re building will actually be pretty expensive. It might be better, and it might be freer, and it might be more patient-centered, but it’s not going to be cheaper.
The other argument you hear is that setting prices means rationing care. In the most stringent systems, like the UK’s, there are worthwhile treatments the government simply refuses to cover, and so patients have to pay for them out-of-pocket.
This is an unacceptable abrogation of freedom — we don’t need government telling us what treatments we can and can’t buy.
This is true, but it’s less of a difference with our system than people realize. We ration care, too — we just do so by letting individuals who can’t afford it go without it.
This rationing by price is a particularly brutal form of rationing, and it’s one reason there’s such persistent political pressure to have the US government ensure access to medical care. It turns out that being free to not be able to afford lifesaving treatments is not a freedom Americans value very highly.
The question Republicans need to grapple with: is a free market system worth the cost?
Republicans have failed to resolve these tensions in their own health care ideas. They say they want to build a generous health care system around private insurance — the most expensive form of insurance — but they also don’t want to spend much money on it. So far, they have tended to try to resolve that dispute by cutting back on the “generous” and “insurance” parts.
This is more or less what the American Health Care Act attempted. But as Republicans learned, Americans don’t want a health care system where 50 million people go uninsured and the remainder struggle with higher deductibles and sparer coverage. This rules out the AHCA, but I think it also rules out the catastrophic care–only systems that are popular with conservative health thinkers.
If Republicans want a more free market system, they are going to have to make peace with the public’s desire for health care that actually is useful when they get sick.
I assume Republican health care wonks are doing some soul searching in the aftermath of the AHCA’s complete and total collapse. This, I think, is where they should start.
A health care system that aligns with conservative principles and actually provides decent, affordable coverage to Americans will be a very expensive system. They need to decide if that’s worth it.
If it isn’t, then Republicans should focus on tax reform, and make peace with the idea that America, like every other country, is going to move toward a system that saves money by turning more and more of the health care system over to the government. If it is, then they need to accept they’re going to have to spend more money, whether through Obamacare or something else.
The truth is the AHCA’s problems were fundamentally problems of money. There’s no reason that age-based tax credits, health savings accounts, and a more flexible Medicaid system have to lead to massive coverage losses.
You could easily have imagined a version of the AHCA with subsidies sufficient to cover everyone — including Medicaid enrollees — with usable private insurance. That would’ve led to a much more free market system than we have now.
But that legislation would have cost even more than Obamacare.
This is the problem Republicans face. America can build a free market health system, or it can build a cheap health system, but it can’t build both.
Republicans need to decide if a conservative health care
Top 10 Most Recent News Articles
Parents Champion Meta's Online Safety Agreement
Any old-timer in the market game will tell you this: safeguarding the next generation runs deeper than just chasing profits. A recent poll by the Coalition to Empower our Future reveals something that ain’t too surprising if you’ve been paying attention. Parents all over the nation are nodding along to Meta’s new move to bolster online protections for younger folks....
Continue Reading
Potomac Edison Eyes Rate Hike for System Overhaul
FirstEnergy's Potomac Edison Pushes for Rate Adjustment The walls are closing in on the energy sector, and Potomac Edison is seizing the moment. With their proposed $52.8 million rate adjustment, they're not only aiming to keep the lights on but to power up their entire infrastructure game. It's a gutsy move, particularly in volatile times. The Price Tag: Weighing Costs...
Continue Reading
Local Climate Resilience Gains Urgency in the Southwest
Local Impact Means Taking Climate Change Personally If you haven't felt it yet, you will. Climate change isn't just a global headline anymore—it's a daily reality that’s reshaping life where you stand. David W. DuBois, New Mexico's top climatologist, is sounding the alarm this time on the new Net Zero Speaks episode, saying it's on us to use local climate knowledge to...
Continue Reading
Halloween 2026: Gemmy's Animatronics Add Thrills
Halloween's New Twist with Gemmy's Animatronics Well, just when you thought Halloween couldn't get any more over the top, here comes Gemmy with their 3-foot tall animatronic characters ready to give your trick-or-treat scene that extra jolt. These aren't just any run-of-the-mill decorations. Nope, they come with a twist—an industrial-strength twist of scares and sweets...
Continue Reading
ASU Teams Up for National Manufacturing Workforce Push
ASU's Role in Reviving American Manufacturing The Foundry School is a big hit for Arizona State University (ASU) as it joins hands with seven other top-tier universities under the U.S. Departments of State and Labor's initiative. This project is all about sculpting the future players of American manufacturing. In a scene highlighted by the Vice President and girded by...
Continue Reading
TrailBlazer Magazine Snags a Tribune for In-House Design
Who Knew? Design Awards Aren't Just for Pretty Pictures TrailBlazer Magazine gets a pat on the back from GDUSA's 2026 Inhouse Design Awards, a nod to top-notch design work. With over 4,000 entries across the board, getting into the top 10 percent is like finding a steakhouse with zero line on a Friday night. Not exactly common, right? Design Worth Cheering For The winning...
Continue Reading
GoDaddy Faces Class Action: Investor Stakes High
GoDaddy's Legal Turbulence: What's at Stake? Sometimes riding the stock wave can hit unexpected snags, and that's what's up with GoDaddy right now. They're stuck in the middle of a securities deception storm that's sending shivers down the spine of many an investor. The Class Action Lawsuit's Core Here's what you need to know: GoDaddy, with its ticker NYSE:GDDY, is...
Continue Reading
Hyundai's Revolutionary US Steel Mill Set for 2029 Rollout
Hyundai's Major Steel Move: A Multibillion-Dollar Stake The steel industry scene in the U.S. just got a lot hotter with Hyundai's announcement of a $5.8 billion Electric Arc Furnace-based integrated steel mill in Louisiana. This game-changing project isn’t just a headline; it’s a concrete step towards beefing up the U.S. manufacturing backbone. Talk about...
Continue Reading
PrimeBOT Shines at IFA 2026 with Innovative Awards
A New Chapter in Home Robotics In today's tech-centric world, newcomers often confuse flash with substance. But every now and then, you catch a glimpse of something that might just change how the world spins. At this year's IFA 2026, PrimeBOT didn't just dip its toes into the limelight—it cannonballed right in, drumming up some serious buzz with its PrimeBOT T1 and...
Continue Reading
AVEX Faces Lawsuit Over IPO Missteps
Legal Storm Brewing with AEVEX's IPO Disclosures Whatever happened to straightforward honesty in business? AEVEX Corp. (NYSE: AVEX) might have forgotten that chapter judging by fresh allegations in their midst. Investors who bought AVEX Class A common stock between April 17 and June 4, 2026, have been hit with a curveball: a looming class action lawsuit for securities...
Continue ReadingTop 5 Most Recently Viewed Articles
Transform Your Investment: The Growth of SPS Commerce Over Time
The Impressive Growth of SPS Commerce SPS Commerce (NASDAQ: SPSC) has carved out a strong position in the market, consistently providing remarkable returns. Over the last 15 years, this company has outpaced average market growth by a staggering 13.26% each year, resulting in an average annual return of 25.11%. As of now, SPS Commerce enjoys a robust market capitalization...
Continue Reading
Dollar Tree Adjusts Annual Forecast Amid Weak Demand Challenges
Dollar Tree Updates Its Annual Forecasts Dollar Tree (NASDAQ: DLTR), a prominent discount store operator, has recently revised its annual forecasts due to a notable drop in demand from budget-conscious shoppers. This change comes as the company struggles to attract customers to its higher-margin products amidst ongoing inflationary challenges. Following this announcement,...
Continue Reading
Join the Class Action Against PepGen Inc. with Confidence
Take Action: Class Action Against PepGen Inc. The Gross Law Firm has initiated an important opportunity for shareholders of PepGen Inc. (NASDAQ: PEPG) to participate in a class action lawsuit. If you invested in PepGen during the specific period defined by the firm, it’s essential to be aware of your rights and options. Understanding the Class Period For shareholders,...
Continue Reading
Air Cargo Market Transformation: Expected Growth Ahead
The Future of the Air Cargo Market The global air cargo industry is on the threshold of a significant transformation. Recent analyses indicate a positive trajectory, with the market projected to achieve a remarkable valuation of USD 210.93 billion by a defined future point. This invigorating growth can be ascribed to multiple factors, notably the burgeoning e-commerce...
Continue Reading
Chiesi Global Rare Diseases and Protalix BioTherapeutics Collaborate for Innovative Treatments
Chiesi Global Rare Diseases and Protalix BioTherapeutics Collaboration Chiesi Global Rare Diseases, a dedicated wing of the Chiesi Group, has taken substantial steps toward advancing therapies for people affected by rare diseases. Collaborating with Protalix BioTherapeutics, this partnership aims to bring innovative solutions to a segment of the population that often...
Continue Reading